Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) SHZ

14.04

-0.46(-3.17%)

Updated at December 05 12:33PM

Currency In CNY

Valuation

Market Cap3.04B
Enterprise Value2.96B
P/E Ratio-23.09
PEG Ratio0.1
Price/Sales Ratio5.05
Price/Book Ratio2.31
Enterprise/Revenue5.61
Enterprise/EBITDA-26.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.22
Operating Margin-0.24

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.09

Income Statement

Revenue1.13B
Revenue/Share2.75
Gross Profit579.91M
EBITDA202.45M
Net Income58.68M
Diluted EPS0.19

Balance Sheet

Total Cash734.94M
Total Cash/Share2.32
Total Debt1.13B
Total Debt/Equity0.59
Current Ratio0.97
Book Value Per Share6.02

Price History

52-Week Change28.53
52-Week High18.18
52-Week Low8.8
Moving Average 50 Days13.78
Moving Average 200 Days13.6

Statistics

Average Volume9.68M
Shares Outstanding316.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield1.44
Payout Ratio-0.54
Last Split Factor3:2
Last Split DateJune 13, 2018